Stocksigma LogoStocksigma Logo

Aurobindo Pharma Faces ₹4.60 Crore Tax Demand via Appellate Order

Aurobindo Pharma received an order dated 28th Sep'26 from the Appellate Joint Commissioner (ST), Hyderabad, confirming a total disputed demand of ₹4.60

Aurobindo Pharma Faces ₹4.60 Crore Tax Demand via Appellate Order

Aurobindo Pharma Ltd · Others (Uncategorized) · 29 Sept 2026, 10:15 pm

Aurobindo Pharma Faces ₹4.60 Crore Tax Demand via Appellate Order Aurobindo Pharma received an order dated 28th Sep'26 from the Appellate Joint Commissioner (ST), Hyderabad, confirming a total disputed demand of ₹4.60 crore for FY21. This comprises a tax reversal of ₹2.56 crore for alleged excess Input Tax Credit claims, ₹1.78 crore in interest, and a ₹0.26 crore penalty. The company plans to appeal the order before the GST Appellate Tribunal and stated the ruling has no material impact on its financials or operations.

Original exchange filing (PDF)

More announcements from Aurobindo Pharma Ltd

All Aurobindo Pharma Ltd announcements